X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Allyson Funk

Allyson Funk Ally is a senior director of public affairs at PhRMA focusing on Medicare, Medicaid, the Affordable Care Act, and other public programs. Her previous experience includes leading health communications for a large membership organization, supporting public affairs clients, and working for the governor of Louisiana. Ally enjoys travel, trying new restaurants and spending time with Buddy, her 9-year-old rescue Pomeranian. In the fall, she and her husband are almost always wearing Saints gear.

Recent Posts

Medicare Monday: How to switch plans during open enrollment

By Allyson Funk  |    October 24, 2016
We’ve talked before about the importance of considering options and switching plans during open enrollment. One recent study noted beneficiaries can save an average of $400 to $600 per year by...   Read More

New Study: Substantial rebates negotiated in Medicare Part D

By Allyson Funk  |    October 12, 2016
A new QuintilesIMS Institute research brief takes a first-of-its-kind look at Part D costs after accounting for rebates across 12 therapeutic classes widely used in Part D. This new report...   Read More

Medicare Monday: New Part D study highlights benefit of switching plans

By Allyson Funk  |    September 26, 2016
With open enrollment beginning on October 15, it’s important for consumers to have adequate information to make the right decision about their health coverage and whether or not they should stay...   Read More

New Survey: Patients’ share of health care costs continues to grow

By Allyson Funk  |    September 20, 2016
As we’ve highlighted before, a growing body of research continues to raise red flags about the implications of high cost sharing and patients’ ability to access affordable care – even if they have...   Read More

Medicare Monday: New research reveals Part D coverage is more robust than VA coverage for new, innovative medicines

By Allyson Funk  |    September 12, 2016
For 10 years, Medicare Part D has successfully provided access to affordable prescription drug coverage to seniors and people living with disabilities thanks to robust competition and negotiation...   Read More

Medicare Monday: Upcoming on the Medicare calendar

By Allyson Funk  |    September 5, 2016
What is coming up this week in the world of Medicare? Tune in to a couple of interesting happenings.   Read More

Empowering consumers and improving access to important clinical information

By Allyson Funk  |    August 29, 2016
Even though more Americans are insured than ever before, many are facing insurance barriers that may interfere with a doctor’s prescribed course of treatment and impact their care. We recently...   Read More

Medicare Monday: Concerns still abound about Part B proposal

By Allyson Funk  |    August 15, 2016
We’ve covered many of the concerns about the government’s overreaching proposal to change Medicare Part B payments and negatively impact seniors’ access to treatment. A lack of patient protections...   Read More

What’s driving insurance premium increases? Hint: It’s not prescription drugs

By Allyson Funk  |    August 2, 2016
A new analysis from Avalere Health looks at 2017 proposed health insurance premium increases. As in 2016, insurers’ own data point to outpatient spending as the largest expected driver of premium...   Read More

Medicare Monday: Part D premiums remain steady, 3 things to know

By Allyson Funk  |    August 1, 2016
Last week, the Centers for Medicare & Medicaid Services announced that average monthly premiums for Medicare Part D prescription drug coverage in 2017 will increase by just $1.50 per month to an...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates